SiccaNova Therapeutics
A biotechnology company developing an oral drug candidate for dry mouth and related gland-function disorders.
¥1.3BSeries A
ParticipantRC
Red Capital Co., Ltd.
Activity from announced rounds
Activity in this selectionnrw-venture-f5757e51
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $8M 1 disclosed · full round size, not this investor’s share